Summary
A 56-year-old Quality Engineer was granted a security clearance despite a history of drug involvement, specifically under Guideline H (Drug Involvement). The Statement of Reasons (SOR) detailed several admitted instances of drug misuse. These included misusing his daughter's Vicodin prescription in October 2011, and a co-worker's Motrin and Vicodin prescriptions from October to December 2006, all while holding a security clearance.
Further admissions included cocaine use in June 2005, and from 1989 to 1993, along with cocaine purchases during the latter period. The applicant also admitted to marijuana use and purchases from approximately 1974 to 1993. These allegations raised disqualifying conditions under Adjudicative Guidelines (AG) ¶ 25(a), ¶ 25(c), and ¶ 25(g).
However, the judge applied mitigating conditions AG ¶ 26(a) and ¶ 26(b), ultimately granting the clearance. The decision was based on the applicant's significant period of abstinence, with the last incident in 2011, and the finding that drug use was primarily for pain management rather than recreation. The applicant also provided credible testimony demonstrating a strong intent to avoid future drug use.
Why the Applicant Prevailed
- The applicant demonstrated a significant period of abstinence from illegal drug use, with the last incident occurring in 2011.
- The applicant's drug use was primarily to cope with pain rather than for recreational purposes.
- The applicant provided credible testimony indicating a strong intent to avoid future drug use.
Conditions Referenced
- AG ¶ 25(a)raisedAny Drug Abuse
- AG ¶ 25(c)raisedIllegal Drug Possession
- AG ¶ 25(g)raisedIllegal Drug Use After Being Granted a Security Clearance
- AG ¶ 26(a)appliedBehavior Happened so Long Ago
- AG ¶ 26(b)appliedDemonstrated Intent Not to Abuse Drugs in the Future
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedJul 13, 2016
- Answer filedAug 13, 2016
- Hearing heldNov 2, 2016
- Decision dateJun 2, 2017
Cite For
- Mitigation of Drug Involvement Under Guideline H
- Consideration of Recency and Frequency of Drug Use
- Whole-person Concept in Security Clearance Determinations